Literature DB >> 34676317

Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls.

Christian Lanz1, Johan Mattsson2, Felix Stickel3, Jean-Francois Dufour3,4, Rudolf Brenneisen1.   

Abstract

BACKGROUND: The endocannabinoids anandamide (N-arachidonoyl ethanolamide [AEA]) and 2-arachidonoyl glycerol (2-AG) are involved in the regulation of neuronal, immune, metabolic, vascular, and reproductory functions.
METHODS: The development and validation of an analytical method for the determination of AEA and 2-AG in human plasma based on liquid-liquid extraction and gas chromatography-mass spectrometry after silylation is described and (pre)-analytical pitfalls are identified.
RESULTS: In contrast to 2-AG, AEA was unstable in whole blood and increased by a factor of 2.3 within 3 h on ice. AEA was stable in plasma on ice for 4 h while 2-AG tended to decrease. Excellent stability at room/ambient temperature was found for both derivatized compounds over 45 h. Furthermore, 3 freeze-thaw cycles revealed a complex pattern: endogenous AEA was stable in plasma but slightly increased in spiked samples (+12.8%), while endogenous 2-AG concentrations increased by 51% and declined by 24% in spiked samples. A long-term study over 4 weeks at -80°C showed that low endogenous AEA and spiked 2-AG concentrations were stable. However, spiked AEA tended to increase (+19%) and endogenous 2-AG significantly increased by 50% after 2 weeks. Food intake 2 h before blood collection showed no effect on AEA concentrations, whereas 2-AG increased significantly by a factor of 3.
CONCLUSIONS: Overall, limited in vitro and/or in vivo/ex vivo chemical stability of endocannabinoids has to be taken into account.
Copyright © 2018 by S. Karger AG, Basel.

Entities:  

Keywords:  2-Arachidonoyl glycerol; Anandamide; Endocannabinoids; Gas chromatography-mass spectrometry; Human plasma; Pitfalls

Year:  2018        PMID: 34676317      PMCID: PMC8489342          DOI: 10.1159/000489032

Source DB:  PubMed          Journal:  Med Cannabis Cannabinoids        ISSN: 2504-3889


  50 in total

1.  Nucleotide sequence of a human cannabinoid receptor cDNA.

Authors:  C Gérard; C Mollereau; G Vassart; M Parmentier
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

2.  Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction.

Authors:  Alexander A Zoerner; Sandor Batkai; Maria-Theresia Suchy; Frank-Mathias Gutzki; Stefan Engeli; Jens Jordan; Dimitrios Tsikas
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-06-22       Impact factor: 3.205

3.  Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry.

Authors:  Daniela Schreiber; Stephanie Harlfinger; Brit M Nolden; Christoph W Gerth; Ulrich Jaehde; Edgar Schömig; Joachim Klosterkötter; Andrea Giuffrida; Giuseppe Astarita; Daniele Piomelli; F Markus Leweke
Journal:  Anal Biochem       Date:  2006-12-20       Impact factor: 3.365

4.  Release of anandamide from blood cells.

Authors:  Michael Vogeser; Daniela Hauer; Shahnaz Christina Azad; Erasmus Huber; Martin Storr; Gustav Schelling
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

5.  Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.

Authors:  B Gatta-Cherifi; I Matias; M Vallée; A Tabarin; G Marsicano; P V Piazza; D Cota
Journal:  Int J Obes (Lond)       Date:  2011-08-16       Impact factor: 5.095

Review 6.  Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Alex Perchuk; Paul A Meozzi; Lester Myers; Zoila Mora; Patricia Tagliaferro; Eileen Gardner; Alicia Brusco; Babatunde E Akinshola; Qing-Rong Liu; Bruce Hope; Shinya Iwasaki; Tadao Arinami; Lindsey Teasenfitz; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

7.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

8.  Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds.

Authors:  A C Howlett
Journal:  Life Sci       Date:  1984-10-22       Impact factor: 5.037

Review 9.  Why do cannabinoid receptors have more than one endogenous ligand?

Authors:  Vincenzo Di Marzo; Luciano De Petrocellis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

10.  Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma.

Authors:  Patricia M W Lam; Timothy H Marczylo; Mona El-Talatini; Mark Finney; Vijaianitha Nallendran; Anthony H Taylor; Justin C Konje
Journal:  Anal Biochem       Date:  2008-05-27       Impact factor: 3.365

View more
  1 in total

1.  Circulating Endocannabinoids in Canine Multicentric Lymphoma Patients.

Authors:  Jennifer K Hay; Samuel E Hocker; Gabrielle Monteith; J Paul Woods
Journal:  Front Vet Sci       Date:  2022-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.